Calsona, Mia Monique A.

HRN: 28-42-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2026
CEFTRIAXONE 1G (VIAL)
02/27/2026
03/06/2026
IV
2 G
OD
Wound Dehiscence; S/P NSVD
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: